FOAMIX

foamix-logo

Foamix has a strong in-house pipeline of drugs for dermatologic, ophthalmologic and gynecologic indications. The Company’s lead product under development is the first-in-class Topical Minocycline Foam addressing large markets in dermatology and ophthalmology. Minocycline foam demonstrated high efficacy and favorable safety in two phase II clinical studies in Acne and Impetigo patients. Foamix Ltd. is a clinical-stage, privately held specialty pharmaceutical company, focused on the development of proprietary topical foams and OilGel™ products for dermatology, gynecology, wounds and burns as well as ophthalmic disorders.

#SimilarOrganizations #People #Financial #Website #More

FOAMIX

Social Links:

Industry:
Clinical Trials Health Care Pharmaceutical

Founded:
2003-01-01

Address:
Rehovot, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.foamix.com

Total Employee:
11+

Status:
Active

Contact:
(972) 893-1623

Email Addresses:
[email protected]

Total Funding:
197 M USD

Technology used in webpage:
IPhone / Mobile Compatible SPF Font Awesome Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Barracuda Networks


Similar Organizations

1200-pharma-logo

1200 Pharma

1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

frontier-biotechnologies-logo

Frontier Biotechnologies

Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.

radius-health-logo

Radius Health

Radius Health develops drug therapies for osteoporosis and women’s health.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.


Current Advisors List

darrell-rigel_image

Darrell Rigel Member of the Board of Directors @ Foamix
Board_member

Current Employees Featured

ilan-hadar_image

Ilan Hadar
Ilan Hadar Chief Financial Officer & Country Manager @ Foamix
Chief Financial Officer & Country Manager

david-domzalski_image

David Domzalski
David Domzalski Chief Executive Officer @ Foamix
Chief Executive Officer

not_available_image

Dov Tamarkin
Dov Tamarkin Co-Founder and CEO @ Foamix
Co-Founder and CEO

iain-stuart_image

Iain Stuart
Iain Stuart Chief Scientific Officer @ Foamix
Chief Scientific Officer

Founder


not_available_image

Dov Tamarkin

Stock Details


Company's stock symbol is NASDAQ:FOMX

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Debt - Foamix

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Debt - Foamix

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Foamix

Official Site Inspections

http://www.foamix.com Semrush global rank: 4.98 M Semrush visits lastest month: 1.7 K

  • Host name: aec037177372cc6cd.awsglobalaccelerator.com
  • IP address: 15.197.225.128
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Foamix"

Foamix - Crunchbase Company Profile & Funding

Foamix has a strong in-house pipeline of drugs for dermatologic, ophthalmologic and gynecologic indications. The Company’s lead product under development …See details»

Foamix Pharmaceuticals Ltd - AnnualReports.com

Foamix Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations for the treatment of …See details»

Foamix Information - RocketReach

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address …See details»

Foamix Pharmaceuticals - LinkedIn

Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology.See details»

Foamix and Menlo Therapeutics to Merge, Creating a Combined

Nov 11, 2019 Cost savings: by utilizing Foamix’s commercial organization and G&A infrastructure, the companies could save approximately $50 million per year versus the stand …See details»

Foamix - Funding, Financials, Valuation & Investors - Crunchbase

Foamix is registered under the ticker NASDAQ:FOMX . Their stock opened with $6.00 in its Sep 17, 2014 IPO. Stock Symbol NASDAQ:FOMX ; Valuation at IPO $128.9M; Money Raised at …See details»

Foamix Pharmaceuticals - Craft

Foamix Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of therapies in dermatology. It utilizes the molecule stabilizing technology …See details»

Foamix Pharmaceuticals Ltd. | Shavit Capital

Foamix, a clinical-stage specialty pharmaceutical company focused on developing and commercializing its proprietary minocycline foam for the treatment of acne, impetigo and other …See details»

Foamix Pharmaceuticals - PitchBook

Foamix Pharmaceuticals General Information Description. Foamix Pharmaceuticals Ltd is a specialty pharmaceutical company. It is focused on the development and commercialization of …See details»

Foamix Management Team | Org Chart - RocketReach

The Foamix management team includes David Schuz (Senior Vice President), David Ruben (quality assurance associate), and Assem Abass (Sales Consulting). Get Contact Info for All …See details»

Foamix - Contacts, Employees, Board Members, Advisors

Foamix has a strong in-house pipeline of drugs for dermatologic, ophthalmologic and gynecologic indications.See details»

皮肤病制药公司:Foamix Pharmaceuticals (FOMX) - 美股之家

May 23, 2015 Foamix Pharmaceuticals Ltd.是一家临床阶段的专业制药公司,致力於开发并销售粉刺、脓包并和其他皮肤病治疗方面的以泡沫为基础配方。 公司的主要候选产品FMX101 …See details»

Foamix - VentureRadar

Foamix Foam and OILGEL platforms for topical dermatological drugs and cosmetics. DermaFoamix alcohol-free foam as a carrier for corticosteroids, anti-bacterial, anti-fungal, anti …See details»

About Foamix (nasdaq FOMX) - partners500.com

About Foamix (nasdaq FOMX) Foamix Ltd. is a clinical-stage, privately held specialty pharmaceutical company, focused on the development of proprietary topical foams and …See details»

Foamix Pharmaceuticals - Overview, News & Similar companies

Foamix Pharmaceuticals Ltd is a company that operates in the Pharmaceuticals industry. It employs 101-250 people and has $10M-$25M of revenue. Is this data correct? View contact …See details»

Foamix Pharm And Menlo Therapeutics To Merge - Quick Facts

Nov 11, 2019 Further, Foamix shareholders will increase pro forma ownership of the combined company to upto 82% based on the results of the Phase III prurigo nodularis trials before May …See details»

Foamix Pharmaceuticals Company Overview, Contact Details

Jul 30, 2019 Foamix partners with Lancashire County Council. After rigorous research and development processes, coupled with live manufacturing and installation trials, in partnership …See details»

Foamix - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Jan 13, 2025 Foamix uses 13 technology products and services including HTML5, Vimeo, and Google Analytics, according to G2 Stack. Foamix is actively using 17 technologies for its …See details»

Foamix(FOMX)首页概览_美股行情_同花顺金融网

公司名称:Foamix Pharmaceuticals Ltd. 上市日期:2014-09-18: 注册地址:State of Israel: 交易所:美国NASDAQ证券交易所: 公司网址:www.foamixpharma.com;www.foamix.com: 员工人 …See details»

Dov Tamarkin - Co-Founder and CEO @ Foamix - Crunchbase

Primary Organization . Foamix . Gender Male; LinkedIn View on LinkedIn ; Dr. Tamarkin is a co-founder of the Company and co-inventor of the Foamix Foam and OilGel technologies. He has …See details»

linkstock.net © 2022. All rights reserved